American Molecular Laboratories (AML) offers somatic mutation analysis using liquid biopsies. AML’s liquid biopsy platform allows for the analysis of wellcharacterized cancer genes in circulating tumor DNA (ctDNA):

  • AML’s ctDNA analysis can detect sequence mutations, insertions/deletions, genomic rearrangements, and amplifications
  • High Sensitivity: Mutations and translocations can be detected down to 0.1% of ctDNA levels